-
1
-
-
0014858698
-
Non-cholinergic transmission by postganglionic motor neurones in the mammalian bladder
-
Ambache N, Zar MA (1970) Non-cholinergic transmission by postganglionic motor neurones in the mammalian bladder, J Physiol (Lond) 210: 761
-
(1970)
J Physiol (Lond)
, vol.210
, pp. 761
-
-
Ambache, N.1
Zar, M.A.2
-
3
-
-
0030607657
-
Characterization of the 5-HT receptor potentiating neurotransmission in rabbit bladder
-
Barras M, Van der Graaf PH, Angel I (1996) Characterization of the 5-HT receptor potentiating neurotransmission in rabbit bladder, Eur J Pharmacol 318: 425
-
(1996)
Eur J Pharmacol
, vol.318
, pp. 425
-
-
Barras, M.1
Van Der Graaf, P.H.2
Angel, I.3
-
4
-
-
0021149603
-
The development of human benign prostatic hyperplasia with age
-
Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132: 474
-
(1984)
J Urol
, vol.132
, pp. 474
-
-
Berry, S.J.1
Coffey, D.S.2
Walsh, P.C.3
Ewing, L.L.4
-
5
-
-
0019361284
-
Electrical and mechanical activity of the isolated lower urinary tract of the guinea-pig
-
Callahan SM, Creed KE (1981) Electrical and mechanical activity of the isolated lower urinary tract of the guinea-pig. Br J Pharmacol 74: 353
-
(1981)
Br J Pharmacol
, vol.74
, pp. 353
-
-
Callahan, S.M.1
Creed, K.E.2
-
6
-
-
0025032172
-
Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract
-
Chen H-I (1990) Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract. Br J Pharmacol 101: 212
-
(1990)
Br J Pharmacol
, vol.101
, pp. 212
-
-
Chen, H.-I.1
-
7
-
-
0029895591
-
Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infrainguinal graft stenosis
-
Cheshire NJ, Wolfe JH, Barradas MA, Chambler AW, Mikhailidis DP (1996) Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infrainguinal graft stenosis. Eur J Endovasc Surg 11: 479
-
(1996)
Eur J Endovasc Surg
, vol.11
, pp. 479
-
-
Cheshire, N.J.1
Wolfe, J.H.2
Barradas, M.A.3
Chambler, A.W.4
Mikhailidis, D.P.5
-
8
-
-
0005438449
-
5-Hydroxytryptamine and non-vascular smooth muscle contraction and relaxation
-
Fozard JR (ed) Oxford University Press, Oxford
-
Cohen ML (1989) 5-Hydroxytryptamine and non-vascular smooth muscle contraction and relaxation. In: Fozard JR (ed) The peripheral action of 5-hydroxytrytamine. Oxford University Press, Oxford, p 201
-
(1989)
The Peripheral Action of 5-hydroxytrytamine
, pp. 201
-
-
Cohen, M.L.1
-
9
-
-
0025232585
-
2 receptors
-
2 receptors. J Urol 143: 1037
-
(1990)
J Urol
, vol.143
, pp. 1037
-
-
Cohen, M.1
-
10
-
-
0024560934
-
Contractile responses in the bladder body, bladder neck and prostate from rat, guinea pig and cat
-
Cohen ML, Drey K (1989) Contractile responses in the bladder body, bladder neck and prostate from rat, guinea pig and cat. J Pharmacol Exp Ther 248: 1063
-
(1989)
J Pharmacol Exp Ther
, vol.248
, pp. 1063
-
-
Cohen, M.L.1
Drey, K.2
-
11
-
-
0026055055
-
Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder
-
Corsi M, Pietra C, Toson G, Trist D, Tuccitto G, Artibani W (1991) Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder. Br J Pharmacol 104: 719
-
(1991)
Br J Pharmacol
, vol.104
, pp. 719
-
-
Corsi, M.1
Pietra, C.2
Toson, G.3
Trist, D.4
Tuccitto, G.5
Artibani, W.6
-
12
-
-
0018074997
-
The effect of pelvic nerve stimulation and some drugs on the urethra and bladder of the dog
-
Creed KE, Tullock AGS (1978) The effect of pelvic nerve stimulation and some drugs on the urethra and bladder of the dog. Br J Urol 50: 398
-
(1978)
Br J Urol
, vol.50
, pp. 398
-
-
Creed, K.E.1
Tullock, A.G.S.2
-
14
-
-
0024424074
-
Concentration-effect relationships and individual responses to doxazosin in essential hypertension
-
Donnelly R, Elliott HL, Meredith PA, Reid JL (1989) Concentration-effect relationships and individual responses to doxazosin in essential hypertension. Br J Clin Pharmacol 28: 517
-
(1989)
Br J Clin Pharmacol
, vol.28
, pp. 517
-
-
Donnelly, R.1
Elliott, H.L.2
Meredith, P.A.3
Reid, J.L.4
-
15
-
-
0029002126
-
Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: A multicenter study
-
Fawzy A, Braun K, Lewis P, Gaffney M, Ice K, Dias N (1995) Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study. J Urol 154: 105
-
(1995)
J Urol
, vol.154
, pp. 105
-
-
Fawzy, A.1
Braun, K.2
Lewis, P.3
Gaffney, M.4
Ice, K.5
Dias, N.6
-
17
-
-
0023267351
-
Interconversion into a low active state protects vascular 5-HT2 receptors against irreversible antagonism by phenoxybenzamine
-
Frenken M, Kaumann AJ (1987) Interconversion into a low active state protects vascular 5-HT2 receptors against irreversible antagonism by phenoxybenzamine. Naunyn Schmiedebergs Arch Pharmacol 335: 481
-
(1987)
Naunyn Schmiedebergs Arch Pharmacol
, vol.335
, pp. 481
-
-
Frenken, M.1
Kaumann, A.J.2
-
18
-
-
0028869716
-
Doxazosin: An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia
-
Fulton B, Wagstaff AJ, Sorkin EM (1995) Doxazosin: an update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs 49: 295
-
(1995)
Drugs
, vol.49
, pp. 295
-
-
Fulton, B.1
Wagstaff, A.J.2
Sorkin, E.M.3
-
19
-
-
0028183017
-
International union of pharmacology classification of receptors for 5-hdroxytryptamine (serotonin)
-
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharne EJ, Saxena PR, Humphrey PP (1994) International union of pharmacology classification of receptors for 5-hdroxytryptamine (serotonin). Pharmacol Rev 6: 157
-
(1994)
Pharmacol Rev
, vol.6
, pp. 157
-
-
Hoyer, D.1
Clarke, D.E.2
Fozard, J.R.3
Hartig, P.R.4
Martin, G.R.5
Mylecharne, E.J.6
Saxena, P.R.7
Humphrey, P.P.8
-
21
-
-
0002586640
-
1-adrenoceptor antagonist, also inhibits serotonin-induced shape change in human platelets
-
1-adrenoceptor antagonist, also inhibits serotonin-induced shape change in human platelets. Br J Pharmacol 127: 91P
-
(1999)
Br J Pharmacol
, vol.127
, pp. 91P
-
-
Jagroop, I.A.1
Mikhailidis, D.P.2
-
22
-
-
0027490595
-
The role of alpha-adrenergic blockers in the treatment of prostatic hypertrophy
-
Jimenez CJF (1993) The role of alpha-adrenergic blockers in the treatment of prostatic hypertrophy. Drugs today 29: 343
-
(1993)
Drugs Today
, vol.29
, pp. 343
-
-
Jimenez, C.J.F.1
-
23
-
-
0028115857
-
Benign prostatic hyperplasia. Current pharmacological treatment
-
Jonler M, Riehmann M, Bruskewitz RC (1994) Benign prostatic hyperplasia. Current pharmacological treatment. Drugs 47: 66
-
(1994)
Drugs
, vol.47
, pp. 66
-
-
Jonler, M.1
Riehmann, M.2
Bruskewitz, R.C.3
-
24
-
-
0022447739
-
Influence of serotonin on lower urinary tract smooth muscle in vitro
-
Klarskov P, Horby-Petersen J (1986) Influence of serotonin on lower urinary tract smooth muscle in vitro. Br J Urol 58: 507
-
(1986)
Br J Urol
, vol.58
, pp. 507
-
-
Klarskov, P.1
Horby-Petersen, J.2
-
25
-
-
0029192883
-
Preoperative cystometrography in patients with clinical benign prostatic hypertrophy
-
Koyanagi T, Ameda K, Nantani M, Taniguchi K, Matsuno T, Shinno Y (1995) Preoperative cystometrography in patients with clinical benign prostatic hypertrophy. World J Urol 13: 24
-
(1995)
World J Urol
, vol.13
, pp. 24
-
-
Koyanagi, T.1
Ameda, K.2
Nantani, M.3
Taniguchi, K.4
Matsuno, T.5
Shinno, Y.6
-
26
-
-
0030464379
-
Recent advances in the treatment of benign prostatic hyperplasia
-
Lai MK (1996) Recent advances in the treatment of benign prostatic hyperplasia. J Formos Med Assoc 95: 822
-
(1996)
J Formos Med Assoc
, vol.95
, pp. 822
-
-
Lai, M.K.1
-
27
-
-
0025256002
-
Binding and functional properties of doxazosin in the human prostatic adenoma and canine brain
-
Lepor H, Baumann M, Shapiro E (1990) Binding and functional properties of doxazosin in the human prostatic adenoma and canine brain. Prostate 16: 29
-
(1990)
Prostate
, vol.16
, pp. 29
-
-
Lepor, H.1
Baumann, M.2
Shapiro, E.3
-
28
-
-
0030948381
-
The influence of age on isometric and isotonic rat detrusor contraction
-
Lieu PK, Sa'adu A, Orugan EO, Malone-Lee JG (1997) The influence of age on isometric and isotonic rat detrusor contraction. J Gerontol 52: M94
-
(1997)
J Gerontol
, vol.52
, pp. M94
-
-
Lieu, P.K.1
Sa'adu, A.2
Orugan, E.O.3
Malone-Lee, J.G.4
-
29
-
-
0029048664
-
5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle
-
Messori E, Rizzi CA, Candura SM, Lucchelli A, Balestra B, Tonini M (1995) 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle. Br J Pharmacol 115: 677
-
(1995)
Br J Pharmacol
, vol.115
, pp. 677
-
-
Messori, E.1
Rizzi, C.A.2
Candura, S.M.3
Lucchelli, A.4
Balestra, B.5
Tonini, M.6
-
30
-
-
0028818877
-
Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia
-
Napalkov P, Maisonneuve P, Boyle P (1995) Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia. Urology 46: 41
-
(1995)
Urology
, vol.46
, pp. 41
-
-
Napalkov, P.1
Maisonneuve, P.2
Boyle, P.3
-
33
-
-
0024382480
-
Pressor responsiveness in essential hypertension and the effects of treatment with an alpha blocker, calcium antagonist or ace inhibitor
-
Reid JH, Donnelly R, Meredith PA, Elliott HL (1989) Pressor responsiveness in essential hypertension and the effects of treatment with an alpha blocker, calcium antagonist or ace inhibitor. Clin Exp Hypertens 11: 247
-
(1989)
Clin Exp Hypertens
, vol.11
, pp. 247
-
-
Reid, J.H.1
Donnelly, R.2
Meredith, P.A.3
Elliott, H.L.4
-
34
-
-
0021683773
-
Aortic recognition sites for serotonin (5-HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover
-
Roth BL, Nakaki T, Chuang DM, Costa E (1984) Aortic recognition sites for serotonin (5-HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology 23: 1223
-
(1984)
Neuropharmacology
, vol.23
, pp. 1223
-
-
Roth, B.L.1
Nakaki, T.2
Chuang, D.M.3
Costa, E.4
-
35
-
-
0025136984
-
2 alpha, serotonin, angiotensin II and VIP
-
2 alpha, serotonin, angiotensin II and VIP. Jpn J Urol 81: 31
-
(1990)
Jpn J Urol
, vol.81
, pp. 31
-
-
Saito, M.1
Gotoh, M.2
Kato, K.3
Kondo, A.4
-
36
-
-
0025902126
-
Influence of aging on the rat urinary bladder function
-
Saito M, Gotoh M, Kato K, Kondo A (1991) Influence of aging on the rat urinary bladder function. Urol Int 47: 39
-
(1991)
Urol Int
, vol.47
, pp. 39
-
-
Saito, M.1
Gotoh, M.2
Kato, K.3
Kondo, A.4
-
37
-
-
0027399384
-
Age-related changes in the response of the rat urinary bladder to neurotransmitters
-
Saito M, Kondo A, Gotoh M, Kato K, Levin RM (1993) Age-related changes in the response of the rat urinary bladder to neurotransmitters. Neurol Urodyn 12: 191
-
(1993)
Neurol Urodyn
, vol.12
, pp. 191
-
-
Saito, M.1
Kondo, A.2
Gotoh, M.3
Kato, K.4
Levin, R.M.5
-
38
-
-
0015715653
-
The actions of 5-hydroytryptamine on the urinary bladder and on vesical autonomic ganglia in the cat
-
Saum WR, de Groat WC (1973) The actions of 5-hydroytryptamine on the urinary bladder and on vesical autonomic ganglia in the cat. J Pharmacol Exp Ther 185: 70
-
(1973)
J Pharmacol Exp Ther
, vol.185
, pp. 70
-
-
Saum, W.R.1
De Groat, W.C.2
-
40
-
-
0030725944
-
Serotonin inhibits nitric oxide synthesis in rat vascular smooth muscle cells stimulated with interleukin-1
-
Shimpo M, Ikeda U, Maeda Y, Kurosaki K, Okada K, Saito T, Shimada K (1997) Serotonin inhibits nitric oxide synthesis in rat vascular smooth muscle cells stimulated with interleukin-1. Eur J Pharmacol 338: 97
-
(1997)
Eur J Pharmacol
, vol.338
, pp. 97
-
-
Shimpo, M.1
Ikeda, U.2
Maeda, Y.3
Kurosaki, K.4
Okada, K.5
Saito, T.6
Shimada, K.7
-
41
-
-
0030068324
-
Benign prostatic hyperplasia in an unselected community-based population: A survey of urinary symptoms, bothersomeness and prostatic enlargement
-
Simpson RJ, Fisher W, Lee AJ, Russell EB, Garraway M (1996) Benign prostatic hyperplasia in an unselected community-based population: a survey of urinary symptoms, bothersomeness and prostatic enlargement. Br J Urol 77: 186
-
(1996)
Br J Urol
, vol.77
, pp. 186
-
-
Simpson, R.J.1
Fisher, W.2
Lee, A.J.3
Russell, E.B.4
Garraway, M.5
-
42
-
-
0027953891
-
Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle
-
Tonini M, Messori E, Franceschetti GP, Rizzi CA, Castoldi AF, Cocini T, Candura SM (1994) Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br J Pharmacol 113: 1
-
(1994)
Br J Pharmacol
, vol.113
, pp. 1
-
-
Tonini, M.1
Messori, E.2
Franceschetti, G.P.3
Rizzi, C.A.4
Castoldi, A.F.5
Cocini, T.6
Candura, S.M.7
-
43
-
-
0027989517
-
Prostatism and the burden of benign prostatic hyperplasia on elderly men
-
Tsang KK, Garraway W (1994) Prostatism and the burden of benign prostatic hyperplasia on elderly men. Age Ageing 23: 360
-
(1994)
Age Ageing
, vol.23
, pp. 360
-
-
Tsang, K.K.1
Garraway, W.2
-
44
-
-
0026076378
-
Biosynthesis and release of tachykinins from rat sensory neurons in culture
-
Vedder H, Otten U (1991) Biosynthesis and release of tachykinins from rat sensory neurons in culture. J Neuroscience Res 30: 288
-
(1991)
J Neuroscience Res
, vol.30
, pp. 288
-
-
Vedder, H.1
Otten, U.2
-
46
-
-
0031013185
-
1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate
-
1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate. J Urol 157: 1032
-
(1997)
J Urol
, vol.157
, pp. 1032
-
-
Walden, P.D.1
Durkin, M.M.2
Lepor, H.3
Wetzel, J.M.4
Gluchowski, C.5
Gustafson, E.E.6
-
47
-
-
0027477729
-
Alfuzosin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia
-
Wilde MI, Fitton A, McTavish D (1993) Alfuzosin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs 45: 410
-
(1993)
Drugs
, vol.45
, pp. 410
-
-
Wilde, M.I.1
Fitton, A.2
McTavish, D.3
|